In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Tekmira siRNA drug protects against Ebola-like virus

This article was originally published in Scrip

Executive Summary

Tekmira Pharmaceuticals' experimental nucleoprotein (NP)-targeting small interfering RNA (siRNA) treatment NP-718m-LNP successfully treated rhesus macaques against the hemorrhagic fever virus Marburg, which is closely related to Ebola – the disease that has been ravaging West Africa, so far killing 1,350 people – scientists reported in the journal Science Translational Medicine.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts